Bosello, Silvia Laura
 Distribuzione geografica
Continente #
NA - Nord America 4.262
EU - Europa 3.774
AS - Asia 3.744
SA - Sud America 761
AF - Africa 107
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 9
Totale 12.677
Nazione #
US - Stati Uniti d'America 4.120
SG - Singapore 1.793
DE - Germania 1.116
CN - Cina 1.033
IT - Italia 661
BR - Brasile 651
SE - Svezia 530
FR - Francia 351
UA - Ucraina 240
IN - India 188
GB - Regno Unito 183
IE - Irlanda 179
ID - Indonesia 140
VN - Vietnam 129
FI - Finlandia 110
PL - Polonia 107
RU - Federazione Russa 94
CA - Canada 75
TR - Turchia 73
KR - Corea 57
HK - Hong Kong 50
MX - Messico 47
AR - Argentina 46
BD - Bangladesh 42
BE - Belgio 42
IQ - Iraq 41
JP - Giappone 38
ZA - Sudafrica 32
AT - Austria 30
NL - Olanda 26
PK - Pakistan 26
ES - Italia 23
IR - Iran 22
MA - Marocco 19
SA - Arabia Saudita 18
VE - Venezuela 18
AU - Australia 17
UZ - Uzbekistan 14
CI - Costa d'Avorio 13
CO - Colombia 13
EC - Ecuador 13
LT - Lituania 13
AE - Emirati Arabi Uniti 12
JO - Giordania 12
KE - Kenya 11
CZ - Repubblica Ceca 9
PT - Portogallo 9
RO - Romania 9
AZ - Azerbaigian 8
CL - Cile 8
TN - Tunisia 7
EU - Europa 6
IL - Israele 6
BG - Bulgaria 5
DK - Danimarca 5
EG - Egitto 5
HU - Ungheria 5
KG - Kirghizistan 5
TW - Taiwan 5
ET - Etiopia 4
HN - Honduras 4
JM - Giamaica 4
MY - Malesia 4
NG - Nigeria 4
NP - Nepal 4
PH - Filippine 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CG - Congo 3
CH - Svizzera 3
CR - Costa Rica 3
KW - Kuwait 3
MD - Moldavia 3
PA - Panama 3
PE - Perù 3
PY - Paraguay 3
RS - Serbia 3
UY - Uruguay 3
AL - Albania 2
BO - Bolivia 2
BY - Bielorussia 2
DZ - Algeria 2
GE - Georgia 2
GR - Grecia 2
KH - Cambogia 2
LB - Libano 2
LV - Lettonia 2
NO - Norvegia 2
OM - Oman 2
SI - Slovenia 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
VA - Santa Sede (Città del Vaticano) 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BZ - Belize 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
Totale 12.659
Città #
Singapore 910
Chandler 591
Ashburn 473
Beijing 178
Dublin 178
Ann Arbor 173
Hefei 169
New York 148
Rome 136
Jacksonville 133
Jakarta 128
Los Angeles 122
Dearborn 121
Munich 107
San Mateo 96
Milan 95
Houston 88
Wilmington 88
Woodbridge 84
Nanjing 83
Seattle 76
Boston 65
Kraków 64
Fairfield 61
Frankfurt am Main 61
Moscow 59
Dallas 58
Seoul 56
São Paulo 56
Kent 53
Nürnberg 48
The Dalles 45
Chicago 42
Ho Chi Minh City 42
Hong Kong 42
Lawrence 42
Marseille 42
Brussels 41
Izmir 40
Helsinki 39
Cattolica 37
Buffalo 36
Nuremberg 36
Bremen 34
Nanchang 34
Tokyo 32
Hanoi 31
Pune 31
Santa Clara 31
Redwood City 28
Düsseldorf 27
Warsaw 27
Brooklyn 26
Princeton 25
Atlanta 24
Guangzhou 24
Hebei 23
London 23
Norwalk 23
Montreal 22
Johannesburg 21
Kunming 21
Orem 21
Paris 21
Hyderabad 20
Rio de Janeiro 20
Stockholm 20
Tianjin 20
Toronto 19
Boardman 18
Chennai 18
Lancaster 18
Phoenix 18
Augusta 16
Baghdad 16
Belo Horizonte 16
Leawood 16
Trieste 16
Turku 16
Cambridge 15
Denver 15
Falls Church 15
Fremont 15
Mexico City 15
Florence 14
North Bergen 14
San Francisco 14
Abidjan 13
Andover 13
Detroit 13
Tashkent 13
Amman 12
Shanghai 12
Bexley 11
Changsha 11
Mountain View 11
Porto Alegre 11
Redmond 11
University Park 11
Hangzhou 10
Totale 6.327
Nome #
The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU) 346
B CELL DEPLETION IN DIFFUSE PROGRESSIVE SYSTEMIC SCLEROSIS: SAFETY, SKIN SCORE MODIFICATION AND IL-6 MODULATION IN AN UP TO THIRTY-SIX MONTHS FOLLOW-UP OPEN-LABEL TRIAL 288
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 254
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 245
Impatto dell’inquinamento ambientale da benzene e PM10 sulla progressione clinica della sclerosi sistemica: un’analisi di correlazione. 232
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. 208
MR imaging of atlantoaxial joint in early rheumatoid arthritis. 201
beta-thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up 185
Proteomic approaches to Sjögren's syndrome: a clue to interpret the pathophysiology and organ involvement of the disease. 182
Atlantoepistrophic magnetic resonance imaging involvement in early rheumatoid arthritis: an aggressive tight control therapy not fully arresting the disease 182
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression 181
Assessment of neurological manifestations in hospitalized patients with COVID-19 172
A vascular endothelial growth factor deficiency characterises scleroderma lung disease 171
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis 169
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 164
Very early rheumatoid arthritis is the major predictor of major outcome: clinical ACR remission and radiographic non-progression. 160
B CELLS IN SYSTEMIC SCLEROSIS: A POSSIBLE TARGET FOR THERAPY 156
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 154
ENVIRONMENTAL POLLUTION AND SYSTEMIC SCLEROSIS: A PILOT STUDY ON BENZENE AND PARTICULATE EXPOSURE AS RISK FACTORS FOR THE SYSTEMIC MANIFESTATIONS 150
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 150
Detection of bone erosions in early rheumatoid arthritis: 3D ultrasonography versus computed tomography 148
Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis 146
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 146
Proteome analysis of biological fluids from autoimmune-rheumatological disorders 144
(AS) TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis. 142
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 142
Sarilumab use in severe SARS-CoV-2 pneumonia 136
Quantitative and semi-quantitative computed tomography analysis of interstitial lung disease associated with systemic sclerosis: A longitudinal evaluation of pulmonary parenchyma and vessels 133
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 130
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. 128
Baseline shoulder ultrasonography is not a predictive marker of response to glucocorticoids in patients with polymyalgia rheumatica: A 12-month followup study 126
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 126
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 124
Adult-onset Still's disease following COVID-19 vaccination 124
Life-threatening arrhythmias in a scleroderma patient: the role of myocardial inflammation in arrhythmic outburst 120
Environmental pollution and systemic sclerosis manifestations: a pilot study on benzene and particulate exposure 118
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 118
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 118
Improved Endothelial Function After Endothelin Receptor Blockade in Patients With Systemic Sclerosis 116
Chronic related group classification system as a new public health tool to predict risk and outcome of COVID-19 in patients with systemic rheumatic diseases: A population-based study of more than forty thousand patients 113
Thymosin β4 and β10 in Sjögren's syndrome: Saliva proteomics and minor salivary glands expression 112
Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study 111
Extension of Lung Damage at Chest Computed Tomography in Severely Ill COVID-19 Patients Treated with Interleukin-6 Receptor Blockers Correlates with Inflammatory Cytokines Production and Prognosis 108
A Comprehensive Natural Language Processing Pipeline for the Chronic Lupus Disease 108
Adult Onset Still's Disease and Radiotherapy treatment for breast cancer: Case report about management of this rare association and literature review 102
Gut microbiota analysis in systemic sclerosis according to disease characteristics and nutritional status 102
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression 101
Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone 101
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 100
Microvascular heart involvement in systemic autoimmune diseases: The purinergic pathway and therapeutic insights from the biology of the diseases 99
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study 98
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 98
An unusual lung involvement in scleroderma: lipoid pneumonia 98
Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study 95
Troponin in Stable Ischemic Heart Disease and Diabetes 94
Interstitial Lung Disease Associated With Autoimmune Rheumatic Diseases: Checklists for Clinical Practice 92
Lung vascular changes as biomarkers of severity in systemic sclerosis-associated interstitial lung disease 91
The human salivary proteome: a critical overview of the results obtained by different proteomic platforms 91
Computer-aided quantification of interstitial lung disease from high resolution computed tomography images in systemic sclerosis: correlation with visual reader-based score and physiologic tests 89
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 89
Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu 88
Concordance and Prognostic Relevance of Different Definitions of Systemic Sclerosis Interstitial Lung Disease Progression 87
The role of PET/CT in connective tissue disorders: systemic sclerosis, Sjögren's syndrome and systemic lupus erythematosus 86
Sixth-month remission as a predictor for twelve-month remission in polymyalgia rheumatica 86
Sudden winter iloprost withdrawal in scleroderma patients during COVID-19 pandemic 85
Risk of burnout and stress in physicians working in a COVID team: A longitudinal survey 84
Treatment strategy introducing immunosuppressive drugs with glucocorticoids ab initio or very early in giant cell arteritis: A multicenter retrospective controlled study 83
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study 82
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 81
Rituximab retention rate in systemic sclerosis: a long term real-life multicentre study 81
Troponin in Stable Ischemic Heart Disease and Diabetes 81
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 81
Multidisciplinary Evaluation of Interstitial Lung Diseases: New Opportunities Linked to Rheumatologist Involvement 81
FUNZIONE CARDIORESPIRATORIA, ARTERIAL STIFFNESS E LIVELLI DI NT-PRO BNP IN PAZIENTI AFFETTI DA ARTRITE REUMATOIDE ALL’ESORDIO 80
Extension of Lung Damage at Chest Computed Tomography in Severely Ill COVID-19 Patients Treated with Interleukin-6 Receptor Blockers Correlates with Inflammatory Cytokines Production and Prognosis 79
Long-term retention rate, adverse event temporal patterns and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-life 79
Chronic related group classification system as a new public health tool to predict risk and outcome of COVID-19 in patients with systemic rheumatic diseases: A population-based study of more than forty thousand patients 78
Sixth-month remission as a predictor for twelve-month remission in polymyalgia rheumatica 76
Subclinical atherosclerosis and endothelial dysfunction in patients with polymyalgia rheumatica: a pilot study 74
Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey 72
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 71
The role of PET/CT in connective tissue disorders: systemic sclerosis, Sjögren's syndrome and systemic lupus erythematosus 71
Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients 70
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 68
Ecografia delle spalle in pazienti con PR: valore diagnostico ma non predittivo 68
Measuring the T-cell down-regulation of TCR-zeta, ZAP-70 and CD28 in arthritis patients: An old tool for new biomarkers 66
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 63
What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19? 63
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology 62
Systemic sclerosis progression INvestiGation (SPRING) Italian registry: Demographic and clinico-serological features of the scleroderma spectrum 62
Ultrasonography involvement of carotid, upper and lower limb arteries in a large cohort of systemic sclerosis patients 62
Arthritis in systemic vasculitis: a retrospective analysis 62
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis 61
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 60
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 60
COVID-19 and intestinal inflammation: Role of fecal calprotectin 59
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case-control study from the Italian national multicenter "SPRING" (Systemic Sclerosis Progression InvestiGation) Registry 58
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 58
European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosis 57
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 57
Totale 11.409
Categoria #
all - tutte 57.061
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.061


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021331 0 0 0 0 0 21 51 20 87 28 107 17
2021/2022800 54 38 23 56 61 44 36 102 39 86 106 155
2022/20231.685 214 235 127 271 83 191 83 138 152 14 56 121
2023/20241.067 36 278 53 57 38 146 73 76 21 31 149 109
2024/20252.587 49 51 218 85 255 114 111 108 355 271 550 420
2025/20263.736 898 211 390 725 1.248 264 0 0 0 0 0 0
Totale 12.863